HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients

Tissue Antigens

Volumn 74, Issue 4, 2009, Pages 308-313

  Cordero, E A A ^b   Veit, T D ^a   Da Silva, M A L ^b   Jacques, S M C ^a   Silla, L M D R ^b   Chies, J A B ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Hepatitis C; Human leukocyte antigen G; Polymorphism; Sickle cell disease

Indexed keywords

HLA G ANTIGEN;

3' UNTRANSLATED REGION; ADULT; ALLELE; ANTIGEN EXPRESSION; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATITIS C; HLA SYSTEM; HOMOZYGOSITY; HUMAN; HUMAN CYTOMEGALOVIRUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RESPIRATORY TRACT INFECTION; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; CASE-CONTROL STUDIES; DISEASE SUSCEPTIBILITY; FEMALE; HEPACIVIRUS; HEPATITIS C; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; MALE; POLYMORPHISM, GENETIC; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 70349337710     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2009.01331.x     Document Type: Article

References (45)

1. Saunthararajah YVE, Embury SH. Sickle cell disease. Churchill Livingstone ed. Philadelphia : Elsevier, 2005.
2. Pauling L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia a molecular disease. Science 1949 : 110 : 543 548.
3. Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997 : 337 : 762 769.
4. Gladwin MT, Kato GJ. Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia. Hematology Am Soc Hematol Educ Program 2005 : 51 7.
5. Zago MA, Silva WA Jr., Franco RF. Hemoglobinopathies and other hereditary hematological diseases in the Brazilian population. Ciência e Cultura: Journal of the Brazilian Association for the Advancement of Science 1999 : 51 : 226 234.
6. Naoum PC, Alvarez Filho F, Domingos CRB, et al. Hemoglobinas anormais no Brasil: prevalência e distribuição geográfica. Rev Bras Pat Clín 1987 : 23 : 68 72.
7. Chies JA, Nardi NB. Sickle cell disease: a chronic inflammatory condition. Med Hypotheses 2001 : 57 : 46 50.
8. Costa RN, Conran N, Albuquerque DM, Soares PH, Saad ST, Costa FF. Association of the G-463A myeloperoxidase polymorphism with infection in sickle cell anemia. Haematologica 2005 : 90 : 977 979.
9. Chies JA, Hutz MH. High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz J Med Biol Res 2003 : 36 : 71 5.
10. Vargas AE, da Silva MA, Silla L, Chies JA. Polymorphisms of chemokine receptors and eNOS in Brazilian patients with sickle cell disease. Tissue Antigens 2005 : 66 : 683 690.
11. Tamouza R, Neonato MG, Busson M, et al. Infectious complications in sickle cell disease are influenced by HLA class II alleles. Hum Immunol 2002 : 63 : 194 199.
12. Tamouza R, Busson M, Fortier C, et al. HLA-E*0101 allele in homozygous state favors severe bacterial infections in sickle cell anemia. Hum Immunol 2007 : 68 : 849 853.
13. Veit TD, Vianna P, Scheibel I, et al. Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. Tissue Antigens 2008 : 71 : 440 446.
14. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol 2008 : 29 : 125 132.
15. Rizzo R, Hviid TV, Govoni M, et al. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 2008 : 71 : 520 529.
16. Baricordi OR, Stignani M, Melchiorri L, Rizzo R. HLA-G and inflammatory diseases. Inflamm Allergy Drug Targets 2008 : 7 : 67 74.
17. LeMaoult J, Rouas-Freiss N, Carosella ED. Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. Autoimmun Rev 2005 : 4 : 503 509.
18. Ober C, Aldrich CL, Chervoneva I, et al. Variation in the HLA-G promoter region influences miscarriage rates. Am J Hum Genet 2003 : 72 : 1425 1435.
19. Harrison GA, Humphrey KE, Jakobsen IB, Cooper DW. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 1993 : 2 : 2200.
20. Chen XY, Yan WH, Lin A, Xu HH, Zhang JG, Wang XX. The 14 bp deletion polymorphisms in HLA-G gene play an important role in the expression of soluble HLA-G in plasma. Tissue Antigens 2008 : 72 : 335 341.
21. Borghi A, Fogli E, Stignani M, et al. Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch Dermatol Res 2008 : 300 : 551 559.
22. Glas J, Torok HP, Tonenchi L, et al. The 14-bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn's disease and is associated with ileocecal resection in Crohn's disease. Int Immunol 2007 : 19 : 621 626.
23. Veit TD, Cordero EAA, Mucenic T, et al. Association of the HLA-G 14 bp polymorphism with systemic lupus erythematosus. Lupus 2009 : 18 : 424 430.
24. Hviid TV, Milman N, Hylenius S, Jakobsen K, Jensen MS, Larsen LG. HLA-G polymorphisms and HLA-G expression in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2006 : 23 : 30 7.
25. Park KS, Park JS, Nam JH, Bang D, Sohn S, Lee ES. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. Tissue Antigens 2007 : 69 : 139 144.
26. Lin A, Yan WH, Xu HH, et al. 14 bp deletion polymorphism in the HLA-G gene is a risk factor for idiopathic dilated cardiomyopathy in a Chinese Han population. Tissue Antigens 2007 : 70 : 427 431.
27. Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R. HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol 2004 : 65 : 39 46.
28. Tan Z, Randall G, Fan J, et al. Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 2007 : 81 : 829 834.
29. Veit TD, Chies JA. Tolerance versus immune response - MicroRNAs as important elements in the regulation of the HLA-G gene expression. Transpl Immunol 2009 : 20 : 229 231.
30. Simon D, Bandinelli E, Roisenberg I. Von Willebrand factor gene polymorphisms in three Brazilian ethnic groups. Hum Biol 2000 : 72 : 1055 1063.
31. Lahiri DK, Nurnberger JI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 1991 : 19 : 5444.
32. Hviid TV, Hylenius S, Hoegh AM, Kruse C, Christiansen OB. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 2002 : 60 : 122 132.
33. Long JC. Multiple Locus Haplotype Analysis, version 3.0. Software and documentation distributed by the author. Department of Human Genetics, University of Michigan Medical School, 4909 Buhl Bldg., Ann Arbor, MI 4819-0618, 1999.
34. Long JC, Williams RC, Urbanek M. An E-M algorithm and testing strategy for multiple-locus haplotypes. Am J Hum Genet 1995 : 56 : 799 810.
35. Abramson JH. WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol Perspect Innov 2004 : 1 : 6.
36. DeVault KR, Friedman LS, Westerberg S, Martin P, Hosein B, Ballas SK. Hepatitis C in sickle cell anemia. J Clin Gastroenterol 1994 : 18 : 206 209.
37. Hasan MF, Marsh F, Posner G, et al. Chronic hepatitis C in patients with sickle cell disease. Am J Gastroenterol 1996 : 91 : 1204 1206.
38. Arruda VR, Eid KA, Zen GC, Goncales NS, Saad ST, Costa FF. Hepatitis C antibody (anti-HCV) prevalence in Brazilian patients with sickle cell diseases. Vox Sang 1993 : 65 : 247.
39. Hassan M, Hasan S, Giday S, et al. Hepatitis C virus in sickle cell disease. J Natl Med Assoc 2003 : 95 : 939 942. (Pubitemid 37296668)
40. Hassan M, Hasan S, Castro O, Giday S, Banks A, Smoot D. HCV in sickle cell disease. J Natl Med Assoc 2003 : 95 : 864 867, 872 874.
41. Adewuyi JO. Prevalence of antibodies to hepatitis C virus among normal blood donors and multi-transfused sickle-cell anaemia patients in Nigeria. Trop Doct 1996 : 26 : 29 30.
42. Torres MC, Pereira LM, Ximenes RA, et al. Hepatitis C virus infection in a Brazilian population with sickle-cell anemia. Braz J Med Biol Res 2003 : 36 : 323 329.
43. Campiotto S, Pinho JR, Carrilho FJ, et al. Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 2005 : 38 : 41 9.
44. Akohoue SA, Shankar S, Milne GL, et al. Energy expenditure, inflammation, and oxidative stress in steady-state adolescents with sickle cell anemia. Pediatr Res 2007 : 61 : 233 238.
45. Martinetti M, Pacati I, Cuccia M, et al. Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus. Int J Immunopathol Pharmacol 2006 : 19 : 369 378.